SCHEMBL24944390

SCHEMBL24944390

CC(C)(C)c1ccc2cc(C(C)(C)CS)n(C3COC3)c2c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21341468 0.87 KCNH2 (0.32) —
SCHEMBL24630687 0.78 KCNH2 (0.33) —
SCHEMBL24943834 0.75 KCNH2 (0.30) —
SCHEMBL21341332 0.74 HSD11B1 (0.36) —
SCHEMBL24943789 0.72 DHFR (0.37) —
SCHEMBL24944391 0.72 ALDH1A1 (0.37) —
SCHEMBL24944392 0.70 CCR9 (0.36) —
SCHEMBL21341333 0.70 HTR7 (0.30) —
SCHEMBL24944395 0.70 HSP90AA1 (0.36) —
SCHEMBL21341469 0.69 HSD11B1 (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230030115-A1 RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF BEIJING TIDE PHARMACEUTICAL CO LTD (CN) 2023-02-02 — — US disclosed
Send feedback